- TOUCH On-Line
The TOUCH Prescribing Program is designed to: Inform prescribers, infusion center healthcare providers, and patients about the risk of progressive multifocal leukoencephalopathy (PML) associated with TYSABRI including the increased risk of PML with treatment duration and prior immunosuppressant use
- TOUCH On-Line
How do I enroll in the TOUCH Prescribing Program? Prescribers, infusion sites, certified pharmacies associated with infusion sites and patients must all enroll in the TOUCH Prescribing Program in order to prescribe, infuse, dispense or receive TYSABRI
- TOUCH On-Line
Distribution of TOUCH Prescribing Program forms is controlled and available only from Biogen directly The educational materials below are available for your convenience
- Overview of the TOUCH Program
Prescribers, infusion sites, certified pharmacies and patients must all enroll in the TOUCH Prescribing Program in order to prescribe, infuse, dispense, or receive TYSABRI
- PowerPoint Presentation
The TOUCH Prescribing Program will track all patients over time, so that Biogen can inform the FDA, prescribers, and patients in a timely manner of information regarding the safety of TYSABRI®
|